5Yang YH,Shen XZ,Jiang ZF,et al. Study on Hemolpilus infiuenzae type B diseases in China: the past, present and future[J]. Pediatr Infeet J, 1998(suppl) :140-142.
6World Health Organization(WHO), Scientific Advisory Group of Experts(SAGE), Global Program for vaccines and immunization,Geneva, June 11-13,1997:1-10.
7Capeding MRZ. The immunogenicity of three hemophilus influenzae type b conjugate vaccines after a primary immunization series in philippine infants[J]. Am J Trop Med Hyg. 1996,55:516-520.
4[1]Pechè re JC.Community-acquired pneumonia in children. West Sussex:Cambridge Med Pub,1995∶ 21-34.
5[6]Kwak YH,Jung HA,Park SE,et al.Serotypes and anti- microbial susceptibility in clinical isolates of Haemophi- lus influenzae from Korean children in prevaccination era.J Korean Med Sci,2000,15(6)∶ 616-622.
6[7]Hsuch Po-Ren, Lin Yung-Ching,Shyr Jainn-Ming,et al.Multicenter surveillance of antimicrobial resistance of a Streptococcus pneumoniae,Haemophilus influenzae,and Moraxella catarrhalis in Taiwan during the 1988～ 1999,respiratory season.Antimicrob Agents Chemother,2000,44(5)∶ 1342-1345.
7[8]Gutmawn L,Williamson R,Collatg E,et al.Mechanisms of betaiactam resistance in Haemophilus influenzae.Eur J Clin Microbinfect Dis,1988,7950∶ 610-615.
8[9]Felmingham D,Gruneberg RN.The Alexander Project 1996-1997:Latest susceptibility data from this international study of bacterial pathogens from community-ac- quired lower respiratory tract infections.J Antimicrobo Chemotherapy,2000,45∶ 191-203.
9WHO. WHO Position paper on haemophilus influenzae type b conjugate vaccines [J] ,WER2006 ,81 (47) :445 - 452.
10World Health Organization ( WHO), Scientific advisory group of experts(SAGE), global program for vaccines and immunization [J), Genera1997 , 11 - 13:1 - 10.
